May 08, 2025

Diet Patterns Affect Menarche Timing

New research reveals healthier diets delay menarche while inflammatory diets accelerate it, potentially impacting long-term health outcomes in women regardless of BMI.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

April 25, 2025

Cinnamon Oil May Trigger Drug Interactions

Cinnamaldehyde may modestly activate drug-metabolizing receptors, raising potential herb–drug interaction concerns.

Conexiant

April 25, 2025

FDA Approves Penpulimab-kcqx for NPC

The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.

Conexiant

April 23, 2025

FDA Targets Petroleum-Based Dyes in Food Supply

The FDA and HHS announced plans to eliminate petroleum-based synthetic food dyes, citing potential health risks and aligning with global safety standards.

Conexiant

April 18, 2025

Early-Life Exposure to Environmental Carcinogens May Increase Risk of Pediatric Papillary Thyroid Cancer

Early-life exposure to ambient fine particulate matter air pollution and outdoor artificial light at night may be associated with an increased risk of papillary thyroid cancer in children and young ad...

The ASCO Post

April 18, 2025

Vaccination May Lower RA Risk

Researchers found no increased risk of rheumatoid arthritis following vaccination. In fact, they observed short-term protective effects against RA.

Conexiant

April 16, 2025

Is Primary Care Becoming Pay-to-Play?

“It’s a way to practice self-preservation in this field that is punishing patients and doctors alike” — one internist explains why some rural physicians are opting for concierge care despite the access trade-offs.

KFF Health News

April 16, 2025

Triple Drug Combo May Halt Enterovirus Infections

All three components have previously completed clinical trials for other applications and established safety profiles in humans.

Conexiant